The retina is a highly metabolically active tissue that requires a substantial blood supply. The retinal circulation supports the inner retina, while the choroidal vessels supply the photoreceptors. Alterations in retinal perfusion contribute to numerous sight-threatening disorders, including diabetic retinopathy, glaucoma and retinal branch vein occlusions. Understanding the molecular mechanisms involved in the control of blood flow through the retina and how these are altered during ocular disease could lead to the identification of new targets for the treatment of these conditions. Retinal arterioles are the main resistance vessels of the retina, and consequently, play a key role in regulating retinal hemodynamics through changes in luminal diameter. In recent years, we have developed methods for isolating arterioles from the rat retina which are suitable for a wide range of applications including cell physiology studies. This preparation has already begun to yield new insights into how blood flow is controlled in the retina and has allowed us to identify some of the key changes that occur during ocular disease. In this article, we describe methods for the isolation of rat retinal arterioles and include protocols for their use in patch-clamp electrophysiology, calcium imaging and pressure myography studies. These vessels are also amenable for use in PCR-, western blotting-and immunohistochemistry-based studies.
Introduction
Understanding how blood flow is controlled in the retina is an important goal, since abnormal blood flow has been implicated in the pathogenesis of a variety of sight-threatening retinal diseases 1, 2, 3, 4 . The retinal circulation, which supplies the inner retinal neurons and glial cells, has an end artery arrangement, with all of the blood from the retinal arteries and arterioles passing through the capillaries to the retinal venules and finally veins 5 . Blood flow in the retina is regulated by the tone of the retinal arteries and arterioles as well as the contractile activity of the pericytes located on the walls of the retinal capillaries and post-capillary venules 6, 7, 8 . The control of retinal vascular tone is complex and is modulated by a range of inputs from the circulatory system and surrounding retinal tissue, including blood gases, circulating molecules and hormones, and vasoactive substances released from the retinal vascular endothelium and macroglia 9, 10, 11 . The retinal arterioles are the small arterial branches of the retina and are composed of a single layer of vascular smooth muscle cells and an inner lining of longitudinally arranged endothelial cells 12, 13, 14 . These vessels form the main site of vascular resistance within the retinal circulation and therefore play an important role in the local control of retinal blood flow. Retinal arterioles regulate capillary blood flow in the retina by dilating or constricting their luminal diameter, mediated by changes in vascular smooth muscle contractility 10, 15, 16 . Understanding the molecular mechanisms through which retinal arterioles regulate retinal perfusion therefore requires preparations where the arteriolar smooth muscle cells can be accessed and studied in conditions as close to physiological as possible.
Ex vivo preparations of isolated retinal blood vessels provide access to the vascular smooth muscle cells, whilst still retaining their functionality and interconnectivity with the underlying endothelium. Most studies to date using isolated vessels have focused on large bovine or porcine arterial vessels (60 -150 µm). These can be mounted in commercially available wire or pressure myograph systems to enable pharmacological interrogation of vascular smooth muscle cell contractile mechanisms
Isolation of Retinal Arterioles
Note: The following protocol is used to isolate retinal arterioles. This method is optimized for rat retinal arterioles but can be used with mouse retinas. The yield of vessels, however, is lower when using mice.
Make up a solution of low Ca
2+ containing Hanks' (LCH) as shown in Table 1 .
NOTE: This solution can be stored for up to 3 days at 4 °C (when using stored LCH, ensure that it equilibrates to room temperature and the pH is correct before use). 2. Assemble the following equipment prior to collection of tissue to ensure rapid microdissection of the retinas: serrated forceps, curved scissors, dissection dish (silicone-coated Petri dish), single edged blade, 2 sets of forceps (blunt) 1 glass Pasteur pipette (fire polished to a smooth but not narrow tip), 1 disposable plastic pipette (with tip trimmed off to increase the aperture to ~ 5 -7 mm), 1 glass round bottom test tube (5 mL) and holder. Decant approximately 50 mL of LCH into a glass beaker and prepare a second beaker to decant waste fluids. NOTE: See Table of Materials for specifications and manufacturer details. 3. Euthanize the rat using CO 2 followed by cardiac puncture to exsanguinate (avoid cervical dislocation or concussion as these may damage blood vessels in the eye). Retract the eyelids with serrated forceps, then use the curved scissors to cut around the orbital muscles and through the optic nerve. Gently extract the eyes from the orbit taking care to cut through any remaining attachments with scissors. 4. Place the eyes immersed in LCH solution on the dissection dish (eyes can be transported on ice in a solution of LCH if necessary). Use one set of blunt forceps to anchor the eye to the dish by holding the orbital muscle attachments or optic nerve; ensure that the anchoring point is as close as possible to the sclera to stabilize the eye. 5. Using the blade, cut through the cornea along the ora serrata and remove the lens by pressing gently on the sclera with forceps. 6. Cut the eye cup in half symmetrically through the optic disc. Using closed forceps gently 'brush' out the retinas from the two halves of the eyecup taking care to remove any remaining attachments at the optic disc. Repeat the process with the second eye and transfer the dissected retinas into the test-tube using the plastic pipette and a small drop of LCH medium. 7. Using the plastic pipette fill the test tube with LCH to ~ 5 mL and allow the retinas to settle to the bottom. 8. Wash the tissue approximately 3 times by removing ~ 4 mL of solution from the tube and adding fresh LCH using the plastic pipette. Where necessary, remove extraneous tissue such as suspensory ligaments, vitreous humor and hairs. 9. Wash the inside of the glass Pasteur pipette (polished tip) with LCH to prevent the tissue from sticking to the pipette. Using the same pipette, remove approximately 4 mL of solution from the test-tube. Then add approximately 2 mL of fresh LCH. 10. Gently dissociate (triturate) the retinas by drawing the tissue through the tip of the glass pipette slowly and expel the contents into the testtube. Note, try not to introduce bubbles at this stage. 11. Repeat step 1.10 until the retinas are broken up to a size of approximately 2 -3 mm 2 . 12. Wash the inside of the pipette with approximately 2 mL of LCH and expel this into the test-tube. Allow the contents to settle to the bottom over 5 -10 min. 13. Repeat the trituration process as outlined in 1.10 -1.12 with a little more force until the tissue pieces are approximately 1 mm 2 in size. Again, allow the tissue to settle for 5 -10 min. 14. Repeat steps 1.10 -1.12 a third time with more force until the contents are fully homogenized and no pieces of retina remain (the solution should become milky in appearance ] i ; see section 3). Dispose of remnants of eye cups and solution removed during the isolation process in accordance with local rules on handling of animal waste. NOTE: While it is advisable to experiment on vessels immediately after isolation, surplus isolate can be stored at 4 °C for up to 8 h.
Arteriolar Pressure Myography
NOTE: Arteriolar pressure myography is carried out as follows using equipment detailed in Figure 1A , B and the Figure 1C (ii-iv)). Do this by gently nudging the occluding tungsten wire slip with an additional section of wire held within the forceps; do not touch the arteriole as it will irreversibly adhere to the forceps. 5. Where necessary (for long arteriole segments), add additional tungsten wire slips over the vessel such that the distance between the occluded and open ends of the vessel is no more than 200 µm; this helps to prevent the arteriole moving out of the field of view upon pressurization. If the vessel has any side branches, these should also be occluded with additional tungsten wire slips. If a side branch cannot be occluded discard the vessel. 6. Perfuse the chamber with 0Ca 2+ Hanks' at 37 °C to remove extraneous retinal tissue and to warm the bath to physiological temperatures.
NOTE: A standard gravity-fed bath perfusion and in-line heater system can be used for this purpose (see Figure 1A) . 0Ca 2+ Hanks' is used to facilitate the cannulation procedure, since removal of external Ca 2+ ensures that the arterioles remain dilated.
7. Fabricate pressurization cannulas from filamented borosilicate glass capillaries (tip diameter ~3 -10 µm depending on the diameter of the vessel to be cannulated; smaller vessels require narrower cannulas; see the Table of Materials) using a microelectrode puller and back-fill with 0Ca 2+ Hanks' solution. Ensure the shank of the cannula is tapered gently towards the tip to facilitate cannulation.
8. Mount the cannula in a pipette holder attached to a 10 mL syringe via a Y-connector and a 3-way tap; this is used to pressurize the system, pressure being recorded using a manometer attached to the other side-arm of the Y-connector (see Figure 1B) . NOTE: A 'helper' pipette is required to assist with the cannulation process. Fabricate the pipette from a borosilicate glass capillary pulled on a microelectrode puller to a tip diameter of 0.5 -2 µm. Heavily fire polish the pipette (often until closed) using a microforge. 9. Carefully position the helper pipette at right angles to the long-axis of the vessel close to the open end using a 3-axis mechanical manipulator (see Figure 1D ). Position the helper pipette just above the vessel, but not touching it. 10. Position the cannulation pipette at the open end of the vessel (see Figure 1D and 2A(i)) using a fine micromanipulator; position the tip immediately adjacent to the opening, as assessed by adjusting the plane of focus on the microscope (at 20X). When both the end of the vessel and the cannula tip are in focus at the same time the cannula is correctly positioned for cannulation (see Figure 2A (ii)). 11. Advance the pressurization cannula into the vessel aperture using the x-axis controls of the fine micromanipulator (see Figure 2A( 
iii)).
Assess the success of cannulation by moving the cannula along the y-axis. If the cannula remains within the vessel it is successfully cannulated (see Figure 2A (iv)). If the cannula moves outside of the vessel, the cannula is likely to be above the vessel; if so repeat step 2.10 -2.11 with the cannula at a lower plane in the z-axis. 12. Upon successful cannulation gently lower the helper pipette onto the vessel to restrain the arteriole. Guide the arteriolar wall over the pressurization cannula with the helper pipette, at the same time as the cannulation pipette is advanced further into vessel lumen to a distance of approximately 30 -50 µm (see Figure 2A (v,vi)). NOTE: This procedure requires simultaneous, controlled movement of both manipulators (helper pipette moving towards the cannula while the cannula moves into the vessel lumen) and will require extensive practice to achieve a high success rate. 13. Change the bath solution to normal Hanks' containing 2 mM Ca 2+ (see Table 1 ) at 37 °C. Typically this causes a slight narrowing of the arteriole and the formation of a tight seal around the pressurization cannula. The helper pipette can then be moved away from the vessel. 14. Allow a tight seal to develop for 15 min. View the vessel using a USB camera (and image acquisition software) attached to the microscope and adjust the focus to maximize the contrast between the vessel boundaries and the external and intraluminal spaces (see Figure 2B ).
Image the vessel at 0.5 -5 frames/s. 15. After 1 min of recording at 0 mmHg, increase the intraluminal pressure to the desired level by closing the 3-way tap attached to the pressurization cannula (see Figure 1B ) and apply a small amount of positive pressure to the system via the syringe. Observe the pressure change on the manometer. NOTE: Pressure can be added in a step wise fashion up to 100 mmHg or to one value for example 40 mmHg (approximating retinal arteriolar pressure in vivo) 23 . The vessel should rapidly dilate confirming successful cannulation. Please note, pressure-induced vasoconstriction (i.e, the myogenic response) will subsequently develop over a period of 15 min, but because of the small size of these vessels, this may not always be visually detectable. 16 . Carefully monitor the vessel during initial pressurization for obvious leaks. Sources of leak may originate from cleaved side branches or inadequate sealing of the cannula to the inside of the arteriole. 1. Watch for intraluminal contents leaving the vessel. Smaller, less obvious leaks may become apparent over time as a drop in pressure on the manometer. If possible, occlude the opening with additional tungsten wire slips taking care not to disturb the cannula. Exclude preparations with obvious leakage from further analysis.
17. Apply the drug of interest abluminally to the vessel prior to, or following, 15 min pressurization depending on the aims of the experiment (the former allows effects on the development of the myogenic tone to be determined, while the latter enables analysis of effects on steady-state myogenic tone). A typical drug delivery system is pictured in Figure 3A .
1. Position the delivery outlet perpendicular to the portion of vessel of interest (as illustrated in Figure 1D ) at a distance ~ 500 µm away from the vessel of interest taking care to ensure that the outlet is optimally angled to fully superfuse the area (see Figure 3B ). Ensure that changes in perfusion do not physically disturb the vessel.
18. Following completion of an experiment, apply a solution of 0Ca 2+ Hanks' containing 10 µM wortmannin (myosin light chain kinase inhibitor) to maximally dilate the vessel to determine the passive diameter. NOTE: The strength of the cannulation seal can be tested at the conclusion of the experiment by raising the intraluminal pressure to >100 mmHg. The majority of vessels will remain attached even at this high pressure indicating a tight seal.
Ca 2+ Imaging
Note: Isolated retinal arterioles are prepared for conventional (microfluorimetry) and confocal Ca 2+ imaging as follows (using equipment detailed in NOTE: Vessels remain viable for up to 6 h (when stored at 4 °C and in the dark); however it is recommended that experiments are commenced as soon as possible to reduce the impact of compartmentalization of the dye in internal organelles or extrusion of the dye over time. 3. Transfer 1 -2 mL of retinal homogenate to a glass-bottomed recording chamber (partially filled with LCH) mounted on the stage of an inverted microscope connected to a Ca 2+ microfluorimetry or confocal microscopy system.
1. Anchor arterioles perpendicular to the direction of flow across the recording chamber, with tungsten wire slips (50 µm diameter, 2 -4 mm in length) spaced ~ 100 -200 µm apart along the vessel length (see Figure 3C ) using a similar technique to that described in step 2.3.
4. Perfuse the bath with normal Ca 2+ Hanks' solution at 37 °C. Position the drug delivery outlet as pictured in Figure 3C and apply drugs to vessels as described in step 2.17.
For conventional Ca
2+ imaging, illuminate the vessel with 340/380 nm light via an oil immersion UV objective (e.g., 100X, NA 1.3) and collect emitted fluorescence at 510 nm via a photon counting photomultiplier tube (PMT). 6. At the end of each experiment, measure background fluorescence by quenching the vessel with a MnCl-containing solution (see Table  1 ). Use background-corrected fluorescence ratios (R-F340/F380) for analysis or convert to intracellular Ca 2+ ([Ca 2+ ] i ) using R min and R max measurements (see Table 1 ; applied prior to quenching 24 ) and the Grynkiewicz equation 
Patch-Clamp Electrophysiology
Note: Whole-cell and single-channel recording is possible from individual arteriolar smooth muscle cells still embedded within their parent arterioles as follows (using equipment detailed in Table of Materials).
1. Isolate and anchor retinal arterioles in the recording chamber as described in steps 1, 2.3, and 3.3. For patch-clamp recording, the tungsten wire slips are spaced 200 -800 µm apart along the vessel. 2. Remove basal lamina surrounding the arteriole and electrically uncouple adjacent smooth muscle cells and underlying endothelial cells prior to patch clamping. To do this, superfuse the vessel with a sequential series of enzyme solutions ( Table 1 ) at 37 °C for the required duration. NOTE: The duration of enzyme exposure is optimized for rat retinal arterioles (protease, ~ 8 min; collagenase, ~ 12 min) and depends on the flow rate of the drug delivery system (~1 mL/min on our set-up) and the unit activities of the batch of enzymes being used. 3. Evaluate the level of digestion on visual separation of endothelial and smooth muscle layers during the collagenase step as shown in Figure  4 . Once separation of the cell layers is observed (as shown in Figure 4B ), apply DNAse I solution (~ 4 min) then terminate the digestion by replacement of the bath solution with normal Ca 2+ Hanks' solution.
4. Remove any remaining strands of basal lamina and/or peripheral neuropile by carefully sweeping the closed tips of fine forceps along the surface of the vessel. 5. Pull and polish glass capillaries (Table of Materials), fill with pipette solution (Table 1 ) and place securely in the pipette holder of the patchclamp headstage. Position the pipette at a 45° angle in relation to the recording chamber and advance it towards the vessel using the coarse setting on a motorized micromanipulator. 6. Select a smooth muscle cell protruding from the vessel wall and whose surface is free from visible debris (see Figure 4B) . Position the tip of the patch pipette vertically over the cell of interest and lower gradually using the fine/slow movement of the micromanipulator to make contact with the smooth muscle membrane. 1. Assess the contact between cell and pipette visually from cell movement and a change in the pipette resistance measured using the membrane (seal) test protocol in the acquisition software (5-10 mV negative step from 0 mV, frequency 25 KHz; see Figure 5A (i)).
7. When the seal resistance has increased 5-fold (e.g., rising from 2 to 10 MΩ; Figure 5A (ii)) apply negative pressure transiently to the back of the pipette holder via a y-connector, 3-way tap, syringe and tubing attached to the pipette holder (assembled in a similar manner to that used in pressurization of arterioles, see Figure 1B ).
8. Repeat applications of negative pressure until a gigaseal (>1 GΩ resistance; as indicated by the membrane test in the acquisition software) is formed ( Figure 5A(iii) ). Note, this process may take 1 -5 min. If a gigaseal fails to form, choose a different cell to patch clamp using a fresh patch pipette. 9. Apply a holding potential to the cell via the acquisition software as per the experiment being performed (typically 0, -40 or -80 mV). 10. Study (on-cell) single channel activity in the present configuration. Alternatively, generate inside-out patches by rapidly retracting the patch pipette from the cell surface after gigaseal formation. 1. As the free ends of the membrane can re-anneal under these conditions remove the pipette from the bath via rapid vertical movement of the manipulator (coarse setting). Rapidly return through the meniscus to remove the reformed membrane leaving only the patch inside the pipette tip.
11. Set the sampling frequency on the acquisition software to 5 KHz and activate continuous recording mode to record channel activity. Apply any voltages changes if required via the software or the amplifier. 12. If required, apply drugs to vessel/membrane patch as described in step 2.17. 13. If membrane stretch is required, apply negative pressure to the posterior of the pipette using the syringe attached to a manometer via a 3-way tap and y-connector. 14. Analyze single channel recordings for open probability and unitary conductance in accordance with standard procedures 26 . 15. For whole cell current recording pull and polish pipettes as per the Table of Materials, fill with pipette solution containing amphotericin B (add 3 mg of amphotericin B to 50 µL of DMSO; add 3-6 µL of this to 1 mL of whole-cell pipette solution; sonicate to mix) and form a seal as per steps 4.6 -4.9. 16. Due to the inclusion of amphotericin B there is no need to rupture the membrane within the pipette tip to gain whole cell access. Monitor access, which will be gained gradually, using the membrane test protocol in the acquisition software (-20 mV step from -40 mV, sample frequency 25 KHz; see Figure 5B ). 17. Automated fitting of capacitive transients in some software yields real-time measurements of access resistance and cell capacitance (alternatively the relative decline of the transients can be assessed by eye). Once the access resistance falls to < 15 MΩ, perform series resistance compensations ( Figure 5C ) using the whole-cell parameter dials (capacitance and series resistance) on the amplifier. 1. To do this, use the automated fitting values to initially set the dials (see Figure 5C (ii)) then increase the series resistance compensation dial (both prediction and correction if available on the amplifier) re-adjusting the whole cell compensations while reducing the capacitive transient (see Figure 5C (iii)). Figure 5C(iv) ). Typically, it is possible to compensate the series resistance by 75% in perforated patch mode (requires lag compensation to be set at maximum).
Taking care not to over compensate (as shown in
18. If no automated fitting is available, start by setting the whole-cell parameters dials to 15 pF and 15 mΩ (typical values for these cells) and then adjust to produce the outputs as shown in Figure 5C (ii). Increase the series resistance compensation dial to ~75% and readjust the whole-cell parameters dials as per Figure 5C (iii). 19. Prior to commencing experimentation note the cell capacitance measurement either from the initial automated fitting or from the dial after manual compensation. NOTE: This value is used to normalize currents to cell size. Compensation for series resistance may need to be adjusted during experimentation as access may continue to improve due to further incorporation of amphotericin B into the patch. 20. Apply drugs to vessels as described in step 2. Representative Results Figure 6A shows a schematic drawing of the rat retinal vascular tree. The diameter ranges of the first order (30 -45 µm), second order (20 -30 µm), and pre-capillary arterioles (8 -20 µm) has been confirmed experimentally in our laboratory by confocal imaging of rat retinal wholemount preparations immunohistochemically labelled for α-smooth muscle actin ( Figure 6B ). Upon dissociation of the retina, primary, secondary and pre-capillary arterioles can be identified based on their caliber and the arrangement of the vascular smooth muscle cells. The first and second order arterioles appear visually similar under bright-field microscopy, but can be distinguished on the basis of their size ( Figure 6C) . The pre-capillary arterioles are the smallest arterial vessels in the preparation and are easily recognizable due to their sparser arrangement of vascular smooth muscle fibers. The isolated arterioles can be clearly differentiated from capillaries and venules within the isolation. Capillaries are apparent as a meshwork of small caliber (4 -10 µm in diameter) vessels, while venules are thin walled and lack smooth muscle cell coverage ( Figure 6C) . Primary, secondary and pre-capillary arterioles are suitable for pressure myography, Ca 2+ imaging and patch-clamp studies. Figure 7 shows a pressure myography experiment where a primary rat retinal arteriole has been cannulated and the intraluminal pressure raised to 40 mmHg. The arteriole is then maintained at this pressure to allow for the development of myogenic tone prior to the addition of 0Ca 2+ Hanks' containing 10 µM wortmannin to obtain the passive diameter of the vessel. Figure 7A shows photomicrographs of the arteriole at various time points during the course of the experiment. A full time-course record showing the changes in vessel diameter over time have been plotted in Figure 7B using custom made edge-detection software 27 . Immediately upon pressurization the vessel dilates, which is then followed by an active myogenic constriction that reaches a steady-state level after 15 min. Addition of 0Ca 2+ Hanks'/wortmannin solution dilates the vessel back to a level similar to that observed immediately following the initial pressure step. As described above, drugs may be applied to the vessels before or following pressurization to investigate the mechanisms underlying the development and maintenance of myogenic tone in these vessels. Using this approach, we have previously shown that stretch-activated Transient Receptor Potential Vanilloid 2 (TRPV2) channels and L-and T-type voltage-gated Ca 2+ channels play a central role in facilitating myogenic tone development in first and second order rat retinal arterioles 20, 21, 22 . We have also reported that large-conductance Ca 2+ activated potassium channels (BK channels) 19, 28 and K v 1-containing voltage-gated K + channels act to oppose myogenic activity in these vessels, since addition of specific inhibitors for each of these channels triggers vasoconstriction ( Figure  7C ). Figure 8 shows examples of conventional and confocal Ca 2+ imaging in retinal arterioles prior to and following exposure to the vasoconstrictor peptide, endothelin-1 (Et-1). In conventional fura-2-based recordings (Figure 8A ), Et-1 (10 nM) elicits a biphasic increase in [Ca 2+ ] i in the retinal arteriolar smooth muscle layer, comprising of an initial transient component followed by a lower sustained component. We have previously characterized the transient and sustained components as being due to Ca 2+ release from the endoplasmic reticulum and Ca 2+ influx from the extracellular space, respectively 29 . Fluo-4-based confocal Ca 2+ imaging provides a more detailed picture of the effects of Et-1 at the cellular level.
In these experiments, it is evident that the smooth graded changes in global [Ca 2+ ] i observed in our microfluorimetry studies result from Et-1 stimulating the activation of repetitive asynchronous [Ca 2+ ] i oscillations in the neighbouring retinal arteriolar smooth muscle cells along the vessel wall (Figure 8B, C; 
30
). Figure 9 shows examples of single-channel and whole-cell patch clamp recordings from retinal arteriolar smooth muscle cells. To date, we have carried out both on-cell and inside-out single channel patch clamp recordings 22, 28 . Figure 9A , B for example, show an on-cell patch clamp recording prior to and following membrane stretch (generated by applying negative pressure to the patch pipette). This particular patch contains two channels which are activated by mechanical stretch. We have previously demonstrated that these currents can be inhibited using TRPV2 channel pore-blocking antibodies 22 . The unitary conductance of the channels (249.71 pS) is also consistent with these currents being mediated by TRPV2 31 .
Whole-cell voltage-activated currents can be evoked using voltage step protocols. Figure 9C shows a family of voltage-activated A-type K + currents recorded using such an approach. These currents become evident when other large currents present in these cells (e.g., BK and Ca + -activated Cl -currents) are blocked using specific pharmacological agents 32, 33 . Currents through non-or weakly voltage-dependent ion channels are typically examined using voltage ramp protocols. We have used such protocols to identify and characterize TRPV2 currents activated by hypotonic stretch 22 and channel agonists ( Figure 9D ) in retinal arteriolar smooth muscle cells. ] i oscillations in the individual smooth muscle cells similar to those observed with Et-1. We have previously shown that these oscillations are triggered by the summation of Ca 2+ sparks (localized Ca 2+ release events) and contribute to the generation of myogenic tone 
Discussion
The protocols described above require practice but should be achievable with minimal troubleshooting. On an average day we would obtain 6 -8 usable arterioles from the isolation and achieve 3 -4 successful experiments. If problems are encountered, however, there are some steps that can be taken to help improve success rates. Occasionally we have found, particularly when using younger rats (< 8 weeks), that the yield of arterioles can be low. To circumvent this problem, we would suggest centrifuging the retinal tissue (10 -30 s at 500 x g) between each of the trituration steps in steps 1.12 -1.14. This often helps to improve the yield of vessels but will also increase the amount of cell debris within the preparation.
When cannulating vessels for pressure myography studies it is important to check the arterioles carefully for any side-branches that may have been cleaved close to the bifurcation site. This represents a common cause of leakage and loss of pressure during experimentation. The main issue that can arise with the [Ca 2+ ] i protocols is the level of dye loading. Poor dye loading leads to low signal-to-noise ratios, while overloading results in disruption of normal Ca 2+ homeostasis. To reduce the likelihood of either of these issues, a small aliquot of retinal homogenate can be removed, and isolated vessels checked periodically during the loading protocol. When undertaking patch-clamp experiments, the success rate of gigaseal formation is highly dependent on how well the basal lamina has been digested. When initially testing this protocol or using new lots of enzymes it may be necessary to adjust the concentration/duration of enzyme digestion. Carefully monitoring the separation of the endothelial and smooth muscle layers will ensure sufficient digestion to remove enough basal laminal to gain access. Careful monitoring is also necessary to avoid over-digestion, which can manifest as the vessel begins to constrict. If this occurs, the smooth muscle cells are often too fragile for patch clamp recording. When applying enzymes, it is important to include DNAse I to ensure removal of strands of DNA liberated from damaged cells during the isolation process. DNA fragments are sticky and cause the forceps to adhere to the arteriole during the final stages of the cleaning As highlighted earlier, a key motivation behind the development of the protocols outlined in this manuscript was to better understand why blood flow is disrupted during retinal vascular diseases. Most of our work to date has focused on diabetic eye disease 28, 33 . Arterioles can be isolated from the retinas of experimental rodent models of diabetes using the methods described in section 1. When experimenting on isolated retinal arterioles from diabetic animals, it is important to try to closely replicate the hyperglycemic conditions experienced by the vessels in vivo. For this reason, we would normally raise the D-glucose levels in our isolation and experimental solutions to 25 mM. Thickening of vascular basement membranes is a well-recognized phenomenon in retinal vessels during diabetes 34, 35 . When using animals with prolonged diabetes (> 1 months disease duration), increased enzyme concentrations or digestion times are often needed to enable the application of patch-clamp recording methods.
An important limitation of using ex vivo isolated retinal arterioles to study retinal vascular physiology and pathophysiology is the loss of the surrounding retinal neuropile. Although removal of the retinal glial and neuronal cells enables easy access to the retinal vascular smooth muscle cells for cell physiology studies, the response of the vessels to vasoactive mediators can change dramatically in the absence and presence of retinal tissue. The actions of adenosine tri-phosphate (ATP), for example, provide a good illustration of this point. In isolated rat retinal arterioles, addition of ATP triggers a robust constriction of the vessels 36 , while in the presence of an intact neuropile, the vessels dilate 37 . Therefore, wherever possible, we usually try to validate key findings from our isolated arteriole preparations using ex vivo retinal whole-mounts and in vivo measurements of vessel diameter and blood flow 16, 37 . Of note, new methods have recently emerged for studying small arterioles and capillaries in whole perfused porcine retinas ex vivo 38, 39 . Such preparations are likely to greatly improve our understanding of how the retinal neuropile regulates retinal arteriolar and capillary tone and how changes in retinal haemodynamics modulate neuronal activity in the retina.
Although the procedures described in this paper are focused on the use of isolated rat retinal arterioles for understanding arteriolar smooth muscle cell physiology, we are currently developing protocols to also enable the study of endothelial cell function in these vessels. In preliminary work, we have been successful in modifying the enzymatic digestion of retinal arteriolar segments to yield viable endothelial cell tubes that are amenable to Ca 2+ imaging and patchclamp recording studies. Cannulation of the isolated arterioles at both ends, enabling intraluminal delivery of drugs, could in the future also enable endothelium-dependent vasodilatory responses to be investigated in these vessels.
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